Advocacy Alert: CDC’s Draft Clinical Practice Guideline for Prescribing Opioids Open for Public Comment
Advocacy Advocacy Alerts Find Your Representatives State FAQs Legal Repository Contact Us Advocacy Alert: CDC’s Draft Clinical Practice Guideline for Prescribing Opioids Open for Public Comment February 17, 2022 via SAMHSA (Substance Abuse and Mental Health...
Advocacy Alert: Statement from SAMHSA Leader on FDA’s Drug Safety Alert on Buprenorphine and Risk for Tooth Decay
Advocacy Advocacy Alerts Find Your Representatives State FAQs Legal Repository Contact Us Advocacy Alert: Statement from SAMHSA Leader on FDA’s Drug Safety Alert on Buprenorphine and Risk for Tooth Decay January 20, 2022 via SAMHSA On January 13, 2022, Miriam...
Advocacy Alert: 2021 Year End Advocacy Update
Advocacy Advocacy Alerts Find Your Representatives State FAQs Legal Repository Contact Us Advocacy Alert: 2021 Year End Advocacy Update December 23, 2021 Did you know that one of the many benefits BHAP members get is regular access to our advocate in Washington, DC,...
Advocacy Alert: July 2021 Advocacy Update for BHAP Members
Advocacy Advocacy Alerts Find Your Representatives State FAQs Legal Repository Contact Us Advocacy Alert: July 2021 Advocacy Update for BHAP Members July 15, 2021 Greetings, BHAP! On behalf of Slingshot Solutions, thank you for your membership in BHAP and your...
A national membership association that provides education and advocacy for those in the behavioral health and addiction treatment industries.
We are the leading and unifying voice of addiction-focused treatment programs.
